The fact that regulators overseas have seen fit to take steps to reduce vaginal mesh complications is just further evidence of the potential harm these devices may cause.
New York, New York (PRWEB) December 18, 2012
As transvaginal mesh lawsuits continue to mount in the U.S., regulators in the United Kingdom have taken action to help reduce complications following surgery involving the use of vaginal meshes for pelvic organ prolapse repair, and vaginal tape for the treatment of stress urinary incontinence, Bernstein Liebhard LLP reports. According to a press release issued by the Department of Health on November 22, 2012, these measures will include developing proposals for a registry for implanted vaginal meshes and tapes to help surgeons compare the outcomes of their treatment.*
“The fact that regulators overseas have seen fit to take steps to reduce vaginal mesh complications is just further evidence of the potential harm these devices may cause,” Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The firm is currently evaluating potential vaginal mesh lawsuits on behalf of women who suffered mesh erosion, pain, scarring, infection and other serious injuries, allegedly due to these products.
Transvaginal Mesh Lawsuits
In July 2011, the U.S. Food & Drug Administration (FDA) warned that there had been a five-fold increase in reports of serious complications associated with the use of transvaginal mesh. The FDA also modified its previous position on the frequency of such complications, stating in the alert that vaginal mesh injuries associated with pelvic organ prolapse repair were not rare.**
Federally-filed vaginal mesh lawsuits pending against several manufacturers have been consolidated in multidistrict litigations now underway in U.S. District Court, Southern District of West Virginia, including In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“ MDL No. 2327”). Bernstein Liebhard LLP partner, Jeffrey Grand, is serving on the Plaintiffs’ Steering Committees in all of these federal litigations.
Consolidated litigations involving Johnson & Johnson Ethicon vaginal mesh products and C.R. Bard devices have also been established in New Jersey Superior Court ( In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10). In additional to his work on the federal litigations, Mr. Grand serves as Co-Liason Counsel in both of these proceedings.
Women who suffered complications following implantation of transvaginal mesh may be entitled to compensation for their medical bills, pain and suffering, and other injuries. Bernstein Liebhard LLP is offering free vaginal mesh lawsuit evaluations to any woman injured by one of these devices. A wealth of information regarding the firm's involvement with the ongoing pelvic mesh litigation can be found at Bernstein Liebhard's website, or call 1-877-779-1414 today.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP